Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Zhen

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2026
Mechanisms of Clinical Resistance to Selective FGFR2 Inhibition by LirafugratinibH Ellis, E R Balasooriya, A Varkaris, et al.
Cell Death & Disease|May 18, 2013
Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinomaX Yu, Y Zhen, H Yang, et al.
Journal of Lipid Research|March 21, 2022
An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motifDeepa Balasubramaniam, Oliver Schroeder, Anna M Russell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2021
Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adultsHyun-Sik Yang, Can Zhang, Becky C Carlyle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activityYan Q Chen, Ye Yang, Eugene Y Zhen, et al.
Circulation|October 11, 2024
Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular MortalityGünther Silbernagel, Yan Q Chen, Hongxia Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2026
A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemiaYe Yang, Anne P Beigneux, Troy L Lowe, et al.
The Journal of Clinical Investigation|October 12, 2023
Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumenYe Yang, Anne P Beigneux, Wenxin Song, et al.
Scientific Reports|April 29, 2026
Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humansArkan Abadi, Yan Q Chen, Shareef Khalid, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2026
Mechanisms of Clinical Resistance to Selective FGFR2 Inhibition by LirafugratinibH Ellis, E R Balasooriya, A Varkaris, et al.
Cell Death & Disease|May 18, 2013
Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinomaX Yu, Y Zhen, H Yang, et al.
Journal of Lipid Research|March 21, 2022
An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motifDeepa Balasubramaniam, Oliver Schroeder, Anna M Russell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2021
Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adultsHyun-Sik Yang, Can Zhang, Becky C Carlyle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activityYan Q Chen, Ye Yang, Eugene Y Zhen, et al.
Circulation|October 11, 2024
Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular MortalityGünther Silbernagel, Yan Q Chen, Hongxia Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2026
A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemiaYe Yang, Anne P Beigneux, Troy L Lowe, et al.
The Journal of Clinical Investigation|October 12, 2023
Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumenYe Yang, Anne P Beigneux, Wenxin Song, et al.
Scientific Reports|April 29, 2026
Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humansArkan Abadi, Yan Q Chen, Shareef Khalid, et al.
Pageof 11